These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 36135715)

  • 1. Prognostic value of tumor-infiltrating immune cells in clinical early-stage oral squamous cell carcinoma.
    Huang Z; Lu Y; Wang W; Xie N; Yi C; Xiong G; Xu X; Zhang M; Wang C
    J Oral Pathol Med; 2023 May; 52(5):372-380. PubMed ID: 36135715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.
    Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z
    BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of tertiary lymphoid structure and tumour infiltrating lymphocytes in oral squamous cell carcinoma.
    Li Q; Liu X; Wang D; Wang Y; Lu H; Wen S; Fang J; Cheng B; Wang Z
    Int J Oral Sci; 2020 Sep; 12(1):24. PubMed ID: 32934197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic implications of preoperative systemic inflammatory markers in oral squamous cell carcinoma, and correlations with the local immune tumor microenvironment.
    Ruiz-Ranz M; Lequerica-Fernández P; Rodríguez-Santamarta T; Suárez-Sánchez FJ; López-Pintor RM; García-Pedrero JM; de Vicente JC
    Front Immunol; 2022; 13():941351. PubMed ID: 35958590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic role of tumour-infiltrating lymphocytes in oral squamous cell carcinoma: A meta-analysis.
    Huang Z; Xie N; Liu H; Wan Y; Zhu Y; Zhang M; Tao Y; Zhou H; Liu X; Hou J; Wang C
    J Oral Pathol Med; 2019 Oct; 48(9):788-798. PubMed ID: 31323145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the prognostic value of tumor-infiltrating CD57+ cells in advanced stage head and neck cancer using QuPath digital image analysis.
    de Ruiter EJ; Bisheshar SK; de Roest RH; Wesseling FWR; Hoebers FJP; van den Hout MFCM; Leemans CR; Brakenhoff RH; de Bree R; Terhaard CHJ; Willems SM
    Virchows Arch; 2022 Aug; 481(2):223-231. PubMed ID: 35451620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analyses of the heterogeneity and prognostic significance of tumor-infiltrating immune cells in non-small-cell lung cancer: Development and validation of an individualized prognostic model.
    Pang Z; Chen X; Wang Y; Wang Y; Yan T; Wan J; Du J
    Int Immunopharmacol; 2020 Sep; 86():106744. PubMed ID: 32623229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study.
    Chen Y; Feng Y; Yan F; Zhao Y; Zhao H; Guo Y
    Front Immunol; 2022; 13():922195. PubMed ID: 35935989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD79A work as a potential target for the prognosis of patients with OSCC: analysis of immune cell infiltration in oral squamous cell carcinoma based on the CIBERSORTx deconvolution algorithm.
    Yao S; Huang Z; Wei C; Wang Y; Xiao H; Chen S; Huang Z
    BMC Oral Health; 2023 Jun; 23(1):411. PubMed ID: 37344840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and validation of a metabolic-related genes prognostic model for oral squamous cell carcinoma based on bioinformatics.
    Zhang J; Ma C; Qin H; Wang Z; Zhu C; Liu X; Hao X; Liu J; Li L; Cai Z
    BMC Med Genomics; 2022 Dec; 15(1):269. PubMed ID: 36566175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A four-hypoxia-genes-based prognostic signature for oral squamous cell carcinoma.
    Zhao C; Zhou Y; Ma H; Wang J; Guo H; Liu H
    BMC Oral Health; 2021 May; 21(1):232. PubMed ID: 33941139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct expression patterns of Toll-like receptor 7 in tumour cells and fibroblast-like cells in oral squamous cell carcinoma.
    Ni YH; Ding L; Zhang DY; Hou YY; Huang X; Hu Q
    Histopathology; 2015 Nov; 67(5):730-9. PubMed ID: 25828894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a Favorable Prognostic Subgroup in Oral Squamous Cell Carcinoma: Characterization of ITGB4/PD-L1
    Ma SR; Liu JF; Jia R; Deng WW; Jia J
    Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Cytotoxic T Lymphocytes and Natural Killer Cell Distribution in Oral Squamous Cell Carcinoma and Oral Epithelial Dysplasia: An Immunohistochemical Study.
    John S; Joseph AP; Raghavan Pillai VB; Ramani P; P J; Ramalingam K
    Cureus; 2024 Mar; 16(3):e56323. PubMed ID: 38628992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel T-cell proliferation-associated gene predicts prognosis and reveals immune infiltration in patients with oral squamous cell carcinoma.
    Cui Y; Cheng Y; Huang W; Liu J; Zhang X; Bu M; Li X
    Arch Oral Biol; 2023 Aug; 152():105719. PubMed ID: 37178584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression and role of tubulin polymerization-promoting protein 3 in oral squamous cell carcinoma.
    Xiao T; Lin F; Zhou J; Tang Z
    Arch Oral Biol; 2022 Nov; 143():105519. PubMed ID: 36058091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor expression of miR-448 is a prognostic marker in oral squamous cell carcinoma.
    Wei H; Yu K; Liu Y; Li L; Wang G
    BMC Cancer; 2020 Aug; 20(1):756. PubMed ID: 32787801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of prognostic genes in oral squamous cell carcinoma microenvironment.
    Zhu L; Zhang X; Chen Y; Yan D; Han J
    Cancer Biomark; 2022; 34(4):523-532. PubMed ID: 35275524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial PD-L1 expression at tumor front predicts overall survival in a cohort of oral squamous cell carcinomas from Sudan.
    Gaafar NM; Osman TA; Elsheikh M; Ahmed IA; Dongre H; Fromreide S; Suleiman AM; Johannessen AC; Nginamau ES; Costea DE
    Clin Exp Dent Res; 2022 Dec; 8(6):1467-1477. PubMed ID: 36177667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A2b and A3 adenosine receptors may act as promotive and prognostic factors in oral squamous cell carcinoma.
    Zeng L; Wang C; Wang Z; Xiong H; Zhang T; Chen W; Hu X; Su T
    J Craniomaxillofac Surg; 2023; 51(7-8):508-515. PubMed ID: 37596174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.